Cite
Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients.
MLA
Kohles, Nikolaus, et al. “Relevance of Circulating Nucleosomes and Oncological Biomarkers for Predicting Response to Transarterial Chemoembolization Therapy in Liver Cancer Patients.” BMC Cancer, vol. 11, no. 1, Jan. 2011, pp. 202–11. EBSCOhost, https://doi.org/10.1186/1471-2407-11-202.
APA
Kohles, N., Nagel, D., Jüngst, D., Durner, J., Stieber, P., & Holdenrieder, S. (2011). Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients. BMC Cancer, 11(1), 202–211. https://doi.org/10.1186/1471-2407-11-202
Chicago
Kohles, Nikolaus, Dorothea Nagel, Dietrich Jüngst, Jürgen Durner, Petra Stieber, and Stefan Holdenrieder. 2011. “Relevance of Circulating Nucleosomes and Oncological Biomarkers for Predicting Response to Transarterial Chemoembolization Therapy in Liver Cancer Patients.” BMC Cancer 11 (1): 202–11. doi:10.1186/1471-2407-11-202.